Home Tags Asthma
Asthma Related Content
Prof Dr Michael Roth poses the big question about asthma and the lack of a cure, discussing the causes and medications used to help control it.
Dr Samantha Walker, Director of Research and Policy details how inequality in the UK leads to poor asthma outcomes
Michael Roth, Research Group Leader at the University Hospital Basel explains what asthma is, its health impact and charts research landscape in the field.
Michael Roth, Research Group Leader at the University Hospital Basel & University Basel share his expertise on asthma and COPD, the most prevalent chronic inflammatory diseases of the lung globally
Asthma UK’s recent report explores the barriers to life-changing treatment for people with uncontrolled asthma, as Joe Farrington-Douglas, Head of Policy and External Affairs at Asthma UK explains.
Katy Beckford and Alex Christie from the Association of Respiratory Nurse Specialists detail precisely why dyspnoea (breathlessness) remains an ongoing battle today
In this interview, Sarah O’Connor, CEO of the Asthma Society of Ireland charts today’s key challenges around asthma in Ireland and beyond
Michael Roth, Research Group Leader at University Hospital Basel argues for the clear need to improve the diagnosis of chronic inflammatory lung diseases
NHS 24 provides an introduction to sudden shortness of breath, which is also known as breathing difficulty (dyspnoea)
Pamela J. Lein at the University of California, Davis discusses the evidence suggesting that pesticides are risk factors for asthma
Kay Boycott, Chief Executive of Asthma UK tells us how using data can transform asthma care today
Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective
A recent report from Asthma UK has shown that nine in ten people (88%), living with asthma in England are in favour of sharing their data to improve NHS services
Prof Dr Michael Roth (PhD), Research Group Leader Pulmonary Cell Research at the University Hospital Basel in Switzerland explains the extent to which asthma and COPD (smoker’s lung) are the most prevalent chronic inflammatory diseases of the lung, globally
Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explores the issue of severe asthma and how our understanding of it is evolving
New research by the National Institutes of Health challenge common practice of increasing doses at early signs of worsening symptoms in asthma
Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies. Asthma is the most common non-communicable chronic inflammatory disease of the lung worldwide with no cure available. In the 2016 EU Symposium on the Awareness of allergic diseases it...
Managing director of the Finnish Allergy, Skin and Asthma Federation, Ilkka Repo explores The Finnish Allergy Programme 2008-2018 and what it sets out to do The Finnish Allergy Programme 2008-2018 was initiated to reduce the burden of allergy in both patients and society. The set-up of the programme was unique....
Michael Roth from University Hospital Basel & University Basel gives a compelling overview of research into asthma and need to develop innovative therapies to treat the disease Asthma is the most frequent common, non-communicable chronic inflammatory airway disease, which is often misdiagnosed and therefore incorrectly treated, even in industrialised countries...
Roberta Savli from EFA provides insight into allergic rhinitis Rhinitis is a very common disorder, far more than just sneezing a couple of days in the year. Allergic rhinitis is a serious chronic respiratory disease that reduces patients’ quality of life and their productivity at work and at school. Despite...
12Page 1 of 2